News

SAMHSA has issued a new advisory. This advisory is intended for healthcare providers, including pediatricians, adolescent medicine specialists, primary care providers, and geriatricians.

Thursday, May 14, 1-2 p.m. ET
SAMHSA’s Center for Financing Reform and Innovation (CFRI) is releasing a report and hosting a webinar titled Revised Regulations for Opioid Treatment Programs: Establishing a Baseline to Measure Progress Over Time.

This paper is part of the Technical Assistance Coalition’s Refocus and Renew: Moving Towards Health series—a 10-paper collection guiding state leaders on SMI and SED treatment, recovery, and whole-person health. More papers from this series will be released on an ongoing basis.

The report and webinar examine existing community-initiated care (CIC) organizations to better understand the strategies and funding mechanisms used to sustain substance use disorder (SUD) services in their communities. Leveraging existing resources and trained community members through CIC organizations can complement and extend SUD services and help mitigate service gaps.

Modern cannabis products have increased significantly in potency over the past few decades, and marijuana-related products are now commonly used by adolescents. In this episode, we explore the intersection of adolescent brain development and the rising potency of today’s cannabis products. We also examine the complex relationship between early cannabis use and psychiatric comorbidities.

When mental illness or substance use causes significant impairments in functioning and individuals experience serious mental illness (SMI)—including bipolar disorder, significant depression, or schizophrenia—or children experience serious emotional disturbances (SEDs), the challenges and level of strain can be insurmountable.